The influence of patient size on patient doses in cardiology

C J Kotre1, J Reay, C-L Chapple

  • 1Regional Medical Physics Department, Newcastle General Hospital, Newcastle-upon-Tyne NE4 6BE, UK. John.Kotre@nuth.northy.nhs.uk

Insights

A new size correction method for cardiology patient dose-area product (DAP) records significantly reduces variations unrelated to patient size. This allows for more accurate radiation dose assessments across all patient sizes, improving diagnostic reference levels.

Area of Science:

  • Medical Physics
  • Radiology
  • Cardiology

Background:

  • Patient radiation dose in cardiology and interventional radiology varies significantly due to procedure complexity and patient size.
  • This variation can mask the impact of patient size on radiation dose measurements like dose-area product (DAP).

Purpose of the Study:

  • To investigate the effectiveness of a previously defined size correction method on cardiology patient dose-area product (DAP) records.
  • To determine if this correction can reduce the correlation between DAP and patient weight.

Main Methods:

  • Applied an experimentally derived size correction factor to cardiology patient DAP records.
  • The correction converts DAP to a value expected for a patient similar in size to ICRP Reference Man, based on patient diameter-DAP relationships.

Main Results:

  • The size correction method was found to significantly reduce the residual correlation between DAP and patient weight.
  • This indicates that the correction effectively accounts for variations in patient size.

Conclusions:

  • Size correction is a valuable tool for standardizing patient radiation dose data in cardiology.
  • This method enables diagnostic reference levels to be set using data from all patients, not just 'standard-sized' ones.

Related Concept Videos

Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...